Latest Trials

Systemic therapy trial

UNiCAB : A Phase II of Single Agent Cabozantinib in Patients With Locally Advanced or Metastatic...

This phase II trial is using an oral drug (Cabozantinib) to treat patients with locally advanced or metastatic clear cell renal cell carcinoma who have previously received or are unable to receive immunotherapy

Status : Recruiting

Systemic therapy trial

MyeChild : International Randomised Phase III Clinical Trial in Children With Acute Myeloid...

This phase III trial is comparing two induction chemotherapy treatments in children with Acute Myeloid Leukaemia (AML)

Status : Recruiting

Systemic therapy trial

rEEcur : International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent...

This phase II/III trial is comparing four widely used chemotherapy regimens for patients with primary refractory and recurrent Ewing Sarcoma

Status : Recruiting

Systemic therapy trial

Destiny-Breast02 : A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study of DS-8201a, an...

This Phase III trial is comparing an anti-HER2-antibody drug with standard of care therapy in patients with pre-treated, HER2-positive breast cancer that has spread to other parts of the body

Status : Recruiting

Systemic therapy trial

ACE-LY-308 : A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of...

This phase III trial is evaluating an oral drug (acalabrutinib) in combination with two other drugs (bendamustine and rituximab) for the treatment of Mantle Cell Lymphoma

Status : Recruiting

Multiple treatment types

OUTRUN : A Randomised Phase II Trial of Osimertinib With or Without Stereotactic Radiosurgery for...

This Phase III trial is comparing the effects of giving an oral drug (Osimertinib) alone and in combination with stereotactic radiosurgery (SRS) in patients with non-small cell lung cancer (NSCLC) that has spread to the brain

Status : Recruiting

Systemic therapy trial

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Abiraterone Acetate Plus...

This Phase II trial is trying to determine how safe and effective the oral drug Abemaciclib is when given together with Abiraterone Acetate plus Prednisone (two other oral drugs) in patients with metastatic castrate resistant prostate cancer

Status : Recruiting

Systemic therapy trial

A Phase 2, Multi-center, Open-label, Randomized Study of Oral Asciminib Added to Imatinib...

This Phase II trial is evaluating the safety and effectiveness of 3 oral drugs (Asciminib, Imatinib, Nilotinib) in patients that have been pre-treated for Chronic Myeloid Leukaemia (CML)

Status : Recruiting

Systemic therapy trial

DYNAMIC-Pancreas : Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Early Stage Pancreatic...

This Phase II/III trial is trying to determine whether a genetic test called “circulating tumour DNA” is an effective way to decide the specific type and duration of chemotherapy patients with localised pancreatic cancer should receive post-surgery

Status : Recruiting

Systemic therapy trial

LEAP-005 : A Multicenter, Open-label Phase 2 Study of Lenvatinib (E7080/MK-7902) Plus Pembrolizumab...

This Phase II trial is trying to determine how safe and effective a combination therapy (with pembrolizumab and lenvatinib) is in treating patients with select advanced cancers

Status : Recruiting

 

Looking for a trial? Use the search functionality to find the trial you are finding.